Related Experiment Video
Updated: Jan 8, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Eye acupuncture therapy for insomnia: a systematic review and network meta-analysis
Zhenyu Shi1, Shuxuan Wang2, Di Sun3
1Hangzhou First People's Hospital Xiasha Campus, Hangzhou, Zhejiang, China.
Objective:
This study aims to comprehensively evaluate the efficacy and safety of eye acupuncture as a treatment modality for insomnia using advanced network Meta-analysis techniques.
Methods:
A systematic and thorough search was performed across eight major databases, spanning from their inception to September 01, 2025, to identify pertinent studies. In accordance with a rigorous screening process, which involved assessing titles, abstracts, and full-text articles, we performed data extraction and quality appraisal.
Results:
A total of 31 studies, which encompassed a diverse range of interventions, were included for detailed analysis and synthesis. The findings revealed that both eye acupuncture (EA) alone and in conjunction with other treatments, such as pharmacotherapy and non-pharmacotherapy interventions, exhibited superior efficacy compared to non-utilization of EA in ameliorating patient conditions, as evaluated through Clinical Effectiveness, Pittsburgh Sleep Quality Index score (PSQI), and Chinese Medicine Symptom Complex Score (CMSCS). The Network Meta-analysis findings revealed notable disparities in Clinical Effectiveness, PSQI, and CMSCS between interventions incorporating EA or its combination with other modalities and those not utilizing EA. Particularly, the combination of EA with body acupuncture (BA) ranked highest in reducing PSQI and CMSCS, while the combination with wrist-ankle acupuncture (WA) showed superior Clinical Effectiveness. Although the funnel plots displayed a mostly symmetrical distribution, indicating potential small sample effects and publication bias, it's crucial to interpret these results alongside clinical syndrome differentiation and treatment strategies.
Conclusions:
Compared to non-utilization of EA, its application demonstrates superior therapeutic efficacy in ameliorating insomnia symptoms among affected individuals. However, further validation through large-scale, multi-center, and high-quality studies is imperative to strengthen this conclusion.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/view/CRD42023491548, identifer: CRD42023491548.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

